| |
|
|
|
vTv Therapeutics Inc.  
|
|
2.07 0.05 (0.02%) |
09-18 16:00 |
|
Open: |
2.05 |
Pre close: |
2.02 |
Target:
|
2.85 
|
|
High: |
2.0799 |
Low: |
1.9918 |
Resistance:
|
2.44
2.85
|
|
Volume: |
283,635 |
Market Cap: |
147M |
Support:
|
1.95
1.65
|
|
|
|
|
|
Technical Analysis |
|
Moving Averages |
MA(5):
|
2.00
|
MACD |
MACD(12,26):
|
-0.09 |
|
MA(20): |
1.97  |
Signal(12,26,9): |
-0.12 |
|
MA(100): |
2.42 |
Stochastic Oscillator |
%K(14,3):
|
72.59 |
|
MA(250): |
2.14 |
%D(3): |
63.74 |
|
Average Volume(K) |
3-Month: |
47220
|
52-Week |
High:
|
4.23 |
|
10-Days: |
20701 |
Low: |
1.35 |
|
RSI |
RSI(14):
|
50.78 |
Change(%): |
39.9 |
|
Financials, Statistics and Valuation |
|
EPS |
-0.433 |
Return on Equity (ttm) |
0.0 |
Shares Out. (M) |
47.96 |
|
EPS Est. Current Year |
-1.060 |
Return on Assets (ttm) |
-143.8 |
Shares Float (M) |
13.07 |
|
EPS Est. Next Year |
-2.250 |
PEG Ratio |
0.00 |
% Held by Insiders |
76.63 |
|
EPS Est. Next Quarter |
0.190 |
Qtrly Rev. Growth |
0.0 |
% Held by Institutions |
1.99 |
|
Forward EPS |
-0.690 |
Gross Profit (p.s.) |
-0.258 |
Shares Short (K) |
1900 |
|
Book Value (p.s.) |
-1.450 |
EBITDA (p.s.) |
-0.471 |
P/E |
-4.78 |
|
Sales Per Share |
0.000 |
Qtrly Earnings Growth |
0.00 |
P/BV |
-1.43 |
|
Profit Margin |
0.00 |
Operating Cash Flow
(M) |
-22.43 |
P/S |
4316.40 |
|
Operating Margin |
-98534.78 |
Levered Free Cash Flow
(M) |
-13.01 |
P/CF |
-4.43 |
|
|
|
|
|
|
